Evidence map›Paper›PMID 29460968›Full record

Observational studyAllergy2018

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.

G Sussman, M Abuzakouk, F Bérard, W Canonica, H Oude Elberink, A Giménez-Arnau, C Grattan, K Hollis, S Hunter, A Knulst and 13 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Allergy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency.The journal of allergy and clinical immunology. Global · 2024
    Article
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 17 institutions in 10 countries.

G SussmanUniversity of Toronto, Toronto, ON, Canada.ORCID 0000-0002-2202-2513
M AbuzakoukCleveland Clinic Abu Dhabi, Abu Dhabi, UAE.ORCID 0000-0003-0802-8342
F BérardClaude Bernard University Lyon, Villeurbanne, France.
W CanonicaIRCCS-Humanitas Research Hospital, Humanitas University, Rozzano-Milano, Italy.ORCID 0000-0001-8467-2557
H Oude ElberinkDepartment of Allergology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A Giménez-ArnauHospital del Mar, Universitat Autònoma, Barcelona, Spain.ORCID 0000-0001-5434-7753
C GrattanGuy's Hospital, London, UK.ORCID 0000-0002-8466-4351
K HollisRTI Health Solutions, Research Triangle Park, NC, USA.
S HunterRTI Health Solutions, Research Triangle Park, NC, USA.
A KnulstUniversity Medical Center, Utrecht, The Netherlands.ORCID 0000-0002-1056-3179
J-P LacourUniversité Nice Sophia Antipolis, Nice, France.ORCID 0000-0001-7663-2053
C LyndeLynderm Research, Toronto, ON, Canada.
A MarslandSalford Royal Hospital, University of Manchester, Salford, UK.
D McBrideRTI Health Solutions, Manchester, UK.ORCID 0000-0002-2545-651X
M MaurerCharité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-4121-481X
A NakonechnaRoyal Liverpool and Broadgreen University Hospitals, Liverpool, UK.ORCID 0000-0002-0141-6361
J Ortiz de FrutosHospital 12 Octubre, Madrid, Spain.
M ReynoldsRTI Health Solutions, Research Triangle Park, NC, USA.
C SweeneyRTI Health Solutions, Research Triangle Park, NC, USA.
H TianNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
K WellerCharité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-4437-0313
D WolinRTI Health Solutions, Research Triangle Park, NC, USA.
M-M BalpNovartis Pharma AG, Basel, Switzerland.ORCID 0000-0002-8612-7680
RTI Health Solutions · USCharité - Universitätsmedizin Berlin · DECleveland Clinic · USGuy's Hospital · GBHumanitas University · ITLynde Centre for Dermatology · CANovartis (Switzerland) · CHNovartis (United States) · USResearch Institute Hospital 12 de Octubre · ESRoyal Liverpool and Broadgreen University Hospital NHS Trust · GBSalford Royal Hospital · GBUniversitat Autònoma de Barcelona · ESUniversité Claude Bernard Lyon 1 · FRUniversité Côte d'Azur · FRUniversity Medical Center Groningen · NLUniversity Medical Center Utrecht · NLUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundASSURE-CSU revealed differences in physician and patient reporting of angioedema. This post hoc analysis was conducted to evaluate the actual rate of angioedema in the study population and explore differences between patients with and without angioedema.

methodsThis international observational study assessed 673 patients with inadequately controlled chronic spontaneous urticaria (CSU). Physicians abstracted angioedema data from medical records, which were compared with patient-reported data. Patients in the Yes-angioedema category had angioedema reported in the medical record and a patient-reported source. For those in the No-angioedema category, angioedema was reported in neither the medical record nor a patient-reported source. Those in the Misaligned category had angioedema reported in only one source. Statistical comparisons between Yes-angioedema and No-angioedema categories were conducted for measures of CSU activity, health-related quality of life (HRQoL), productivity and healthcare resource utilization (HCRU). Regression analyses explored the relationship between Dermatology Life Quality Index (DLQI) score and angioedema, adjusting for important covariates.

resultsAmong evaluable patients, 259 (40.3%), 173 (26.9%) and 211 (32.8%) were in the Yes-angioedema, No-angioedema and Misaligned category, respectively. CSU activity and impact on HRQoL, productivity, and HCRU was greater for Yes-angioedema patients than No-angioedema patients. After covariate adjustment, mean DLQI score was significantly higher (indicating worse HRQoL) for patients with angioedema versus no angioedema (9.88 vs 7.27, P < .001). The Misaligned category had similar results with Yes-angioedema on all outcomes.

conclusionsAngioedema in CSU seems to be under-reported but has significant negative impacts on HRQoL, daily activities, HCRU and work compared with no angioedema.

Indexed as

Activities of Daily LivingAdultAgedAged, 80 and overAngioedemaChronic DiseaseFemaleHealth SurveysHumansInternationalityMaleMiddle AgedPatient Acceptance of Health CarePhysician-Patient RelationsQuality of LifeRegression Analysisangioedemaeconomic burdenobservational studyquality of lifeurticaria

Identifiers

PMID29460968
PMCPMC6055840
OpenAlexW2792948845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.